Form 4: Illumina Director Robert Epstein Receives Restricted Stock Unit Grant

Illumina, Inc. Director Robert S. Epstein was granted 3,780 restricted stock units, increasing his beneficial ownership to 22,139 shares, as reported in a recent SEC Form 4 filing.

Summary

• Robert S. Epstein, a Director at Illumina, Inc. (ILMN), reported a change in beneficial ownership of the company's common stock.
• On May 21, 2025, Dr. Epstein acquired 3,780 shares of common stock through a grant of restricted stock units (RSUs).
• These RSUs were granted at a price of $0 and are subject to vesting conditions.
• Following this transaction, Dr. Epstein's total beneficial ownership of Illumina common stock stands at 22,139 shares.
• Additionally, Dr. Epstein's unvested RSUs were increased by 53 units as a result of adjustments related to Illumina's spin-out of Grail, Inc., which was completed on June 24, 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard equity grant to a director, aligning interests, and includes an adjustment for a corporate spin-off, indicating proper handling of equity awards.

Positives

• The grant of 3,780 restricted stock units to Director Robert S. Epstein aligns his interests with those of shareholders, as the value of these units is tied to the company's stock performance.
• The adjustment of unvested RSUs by 53 units due to the Grail spin-out ensures continuity and fairness in equity compensation following a significant corporate event.

Future Outlook

The granted restricted stock units are subject to vesting, which will occur on the earlier of the one-year anniversary of the grant date or the day preceding the company's annual meeting for the year following the grant, contingent on continued service as a director.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction, common across all publicly traded companies, reflecting standard director compensation practices within the biotechnology and life sciences industry.

Corporate Governance

Related Party Transactions

• Grant of 3,780 restricted stock units to Robert S. Epstein, a director of Illumina, Inc., as part of his compensation package.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns management's interests with shareholder value creation, as the value of the compensation is tied to the company's stock performance.
• Director (Robert S. Epstein): Receives additional equity compensation, increasing his stake in the company and incentivizing long-term performance.

Next Steps

• Vesting of the 3,780 restricted stock units based on continued service as a director, occurring on the earlier of the one-year anniversary of the grant date or the day preceding the next annual meeting.

Key Dates

Keywords

Illumina, ILMN, Robert S. Epstein, Form 4, SEC Filing, Restricted Stock Units, RSU Grant, Insider Transaction, Beneficial Ownership, Director Compensation, Equity Compensation